Massachusetts Financial Services
OCDX

Massachusetts Financial Services’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Massachusetts Financial Services’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-56,189
Closed -$1.2M – 923
2021
Q4 		$1.2M Buy
+56,189
New +$1.11M ﹤0.01% 808

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VI
Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Massachusetts Financial Services's OCDX Position: Q1 2022 in Review

Massachusetts Financial Services sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 56,189 shares — an estimated $1.2M sold.

Massachusetts Financial Services first reported a position in OCDX in Q4 2021 and held it in 1 quarter. The position peaked at $1.2M in Q4 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Massachusetts Financial Services reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Massachusetts Financial Services sold 56,189 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $1.2M.
  • Massachusetts Financial Services first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 1 quarter.
  • Massachusetts Financial Services's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.2M in Q4 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Massachusetts Financial Services's 13F filing for Q1 2022, filed 11 May 2022.